Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case report.
Transl Lung Cancer Res
; 9(3): 787-792, 2020 Jun.
Article
en En
| MEDLINE
| ID: mdl-32676339
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Año:
2020
Tipo del documento:
Article